Ginkgo Bioworks Holdings, Inc. short interest in 2026
In 2026, Ginkgo Bioworks Holdings, Inc.'s disclosed short interest ran from 11.60% of shares outstanding on 15 Jan 2026 to 10.64% on 15 Sep 2026, a change of -0.96 percentage points. The year's high was 12.93% on 13 Mar 2026 and its low 6.93% on 15 May 2026, averaging 9.52% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.36 days on 30 Jan 2026. Full history: Ginkgo Bioworks Holdings, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 11.60% (15 Jan 2026)
- End of year
- 10.64% (15 Sep 2026)
- Change
- -0.96 pp
- High
- 12.93% (13 Mar 2026)
- Low
- 6.93% (15 May 2026)
- Average
- 9.52%
- Highest days to cover
- 8.36 (30 Jan 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 11.60% | 7.82 | |
| 30 Jan 2026 | 11.05% | 8.36 | |
| 13 Feb 2026 | 11.98% | 4.82 | |
| 27 Feb 2026 | 12.09% | 6.82 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 12.93% | 5.77 | |
| 31 Mar 2026 | 9.93% | 5.17 | |
| 15 Apr 2026 | 9.85% | 5.82 | |
| 30 Apr 2026 | 8.01% | 4.95 | |
| 15 May 2026 | 6.93% | 2.74 | 10-Q filed, results (8-K) |
| 29 May 2026 | 6.98% | 4.89 | |
| 15 Jun 2026 | 7.51% | 3.31 | |
| 30 Jun 2026 | 7.90% | 4.02 | |
| 15 Jul 2026 | 7.97% | 4.96 | |
| 31 Jul 2026 | 7.90% | 6.67 | |
| 14 Aug 2026 | 8.31% | 4.25 | results (8-K), 10-Q filed |
| 31 Aug 2026 | 10.19% | 5.49 | |
| 15 Sep 2026 | 10.64% | 7.20 |
See also: Ginkgo Bioworks Holdings, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.